Fig. 6From: miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3Schematic representation of miR-29b-3p inhibitor regulated miR-29b-3p mediated NF-κB pathwayBack to article page